Rad Tech CE, ASRT, ARRT® CE, Category A Credits | Radiology Continuing Education

Approvals/Requirements Satisfied by eRADIMAGING Courses

  • ASRT approval for ARRT Category A credit
  • All Courses eligible of international radiographers' CPD requirements
  • ASRT and MDCB are approved continuing education providers of ARRT and all courses are accepted by ARRT
  • California CE requirements met for all radiography courses
  • NMTCB accepted (All Courses)
  • All Courses available for RRAs
  • ARMRIT accepted (All MRI Courses)
  • MDCB approval by the Medical Dosimetrist Certification (Selected Courses)
  • Florida approval for all courses 1 credit or more
  • ARDMS accepted (All Courses)
  • CAMRT and Sonography Canada recognize the ASRT approval (All Courses)
  • Approval: This course is approved by ASRT - an approved continuing education provider of ARRT.
  • Release Date: 1/24/2023
  • Expiration Date: 2/1/2026
  • Credit Hours: 4.5 Credits
  • Course Description and objectives:

    Course Description
    Prostate cancer (PCa) is the second-most common type of cancer diagnosed in men worldwide, with about 1 in 9 men being diagnosed with PCa in their lifetime. Men with PCa often experience no symptoms in its early stages, and diagnostic techniques are either invasive, resource intensive, or have low efficacy, making widespread early detection very difficult. Recently, multimodality radiologic imaging has become extremely important in diagnosing and staging, as well as post-treatment evaluation and detecting recurrences of PCa. Typically, only 2 diagnoses, benign prostatic hyperplasia and PCa, cover more than 95% of cases of PCa disease. Current diagnostic tools and treatment goals are focused on identifying and treating patients with adverse high-risk tumors, while minimizing overtreating those with low-risk tumors. The most common method for detecting PCa is a systematic sonography-guided prostate biopsy in those with elevated prostate-specific antigen levels and/or positive findings on a digital rectal examination. However, using only these methods can sometimes fail to diagnose all patients. As a result, multiple modalities and/or testing strategies are often employed. Transrectal ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) are also used for early detection and recurrence of PCa, as well as for detecting distant metastases. Nuclear imaging-based positron emission tomography (PET)-CT is also a rapidly developing technique that helps compensate for the limitations of whole-body evaluation and precise prognosis prediction. As PCa and other diseases and conditions of the prostate can be difficult to detect, it's imperative that radiologic technicians (RTs) of all modalities be well versed in the best strategies for conducting common tests and imaging studies and how they should be employed. This course will provide an overview of imaging modalities currently used for diagnosing men with PCa, and other diseases of the prostate, including sonography, MRI, CT, and PET-CT, along with step-by-step procedures, safety considerations, and patient preparations for each. It will also outline the value of these modalities in distinct clinical scenarios, ranging from initial diagnosis to biopsy guidance techniques, treatment monitoring, and detection of metastasis. A detailed overview of the anatomy of the prostate, tumor staging and grading scales, and examples of various diseases of the prostate and how they appear on screen will also be provided.

    Learning Objectives
    After completing this course, the participant should be able to:

    • IDENTIFY the function and anatomy as well as the zonal anatomy of the prostate.
    • OUTLINE screening guidelines and recommendations of prostate gland testing protocols.
    • STATE the role of prostate antigen testing.
    • EXPLAIN the role of transrectal ultrasound in diagnosing patients with prostate cancer (PCa).
    • DIFFERENTIATE various biopsy techniques used to diagnose patients with PCa and the Prostate Imaging Reporting and Data System (PI-RADS).
    • RECALL TNM and Gleason scoring PCa staging categories and their descriptors.
    • SUMMARIZE the roles that computed tomography (CT), magnetic resonance imaging, and positron emission tomography (PET)-CT play in imaging the prostate.
    • EXPLAIN the role of bone scintigraphy in detecting prostate cancer metastasis.
    • SUMMARIZE the role of PET-CT in PCa, disease staging, and treatment monitoring.
    Categories: Ultrasound/Sonography, CT, MRI, Nuclear Medicine

  • CE Information:

    In order to receive CE credit, you must first complete the activity content. When completed, go to the "Take CE Test!" link to access the post-test.

    Submit the completed answers to determine if you have passed the post-test assessment. You must answer 30 out of 40 questions correctly to receive CE credit. You will have no more than 3 attempts to successfully complete the post-test.

    Participants successfully completing the activity content and passing the post-test will receive 4.5 ARRT Category A credits.

    Approved by the American Society of Radiologic Technologists for ARRT Category A credit.

    Approved by the state of Florida for ARRT Category A credit.

    Texas direct credit.

    This activity may be available in multiple formats or from different sponsors. ARRT does not allow CE activities such as Internet courses, home study programs, or directed readings to be repeated for CE credit in the same biennium.

  • Structured Education Credit Valuations:

    CategoryContent AreaCredits
    Computed TomographyProcedures0.75
    Magnetic ResonanceProcedures1
    Nuclear MedicineProcedures1
    PTHProcedures0.5
    Radiation TherapyPatient Care1
    Radiation TherapyProcedures0.75
    Radiologist AssistantProcedures2
    SonographyProcedures1

  • CQR Credit Valuations:

    CategorySubcategoryCredits
    Computed TomographyAbdomen and Pelvis0.75
    Magnetic ResonanceBody1
    Nuclear MedicineEndocrine and Oncology Procedures1
    PTHTreatment Sites0.5
    Radiation TherapyPatient and Medical Record Management1
    Radiation TherapyTreatment Sites and Tumors0.75
    Radiologist AssistantAbdominal Section 2
    SonographySuperficial Structures and Other Sonographic Procedures1


Imaging the Prostate: The Roles of Sonography, CT, MRI, and PET

George Tsoukatos, BPS, R.T.(R)(ARRT)®

*Medical Imaging Consultant, Radiology Support Services, Germantown, NY

Address correspondence to: George Tsoukatos, BPS, R.T.(R)(ARRT)®, Radiology Support Services, PO Box 215, Germantown, NY 12526. Email: radiologytechnique@gmail.com.

Disclosure statement: The author reports having no significant financial or advisory relationships with corporate organizations related to this activity.

ABSTRACT

Prostate cancer (PCa) is the second-most common type of cancer diagnosed in men worldwide, with about 1 in 9 men being diagnosed with PCa in their lifetime. Men with PCa often experience no symptoms in its early stages, and diagnostic techniques are either invasive, resource intensive, or have low efficacy, making widespread early detection very difficult. Recently, multimodality radiologic imaging has become extremely important in diagnosing and staging, as well as post-treatment evaluation and detecting recurrences of PCa. Typically, only 2 diagnoses, benign prostatic hyperplasia and PCa, cover more than 95% of cases of PCa disease. Current diagnostic tools and treatment goals are focused on identifying and treating patients with adverse high-risk tumors, while minimizing overtreating those with low-risk tumors. The most common method for detecting PCa is a systematic sonography-guided prostate biopsy in those with elevated prostate-specific antigen levels and/or positive findings on a digital rectal examination. However, using only these methods can sometimes fail to diagnose all patients. As a result, multiple modalities and/or testing strategies are often employed. Transrectal ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) are also used for early detection and recurrence of PCa, as well as for detecting distant metastases. Nuclear imaging-based positron emission tomography (PET)-CT is also a rapidly developing technique that helps compensate for the limitations of whole-body evaluation and precise prognosis prediction. As PCa and other diseases and conditions of the prostate can be difficult to detect, it's imperative that radiologic technicians (RTs) of all modalities be well versed in the best strategies for conducting common tests and imaging studies and how they should be employed. This course will provide an overview of imaging modalities currently used for diagnosing men with PCa, and other diseases of the prostate, including sonography, MRI, CT, and PET-CT, along with step-by-step procedures, safety considerations, and patient preparations for each. It will also outline the value of these modalities in distinct clinical scenarios, ranging from initial diagnosis to biopsy guidance techniques, treatment monitoring, and detection of metastasis. A detailed overview of the anatomy of the prostate, tumor staging and grading scales, and examples of various diseases of the prostate and how they appear on screen will also be provided.

View the full content

Sample eRADIMAGING Course *

* This sample course is for reference purposes only. It is not currently available for earning CE credits. To earn ARRT CE credits please subscribe to eRADIMAGING where you will see a complete listing of all active and eligible CE courses.

Become a member

Satisfy your CE requirements today!

Join now

We offer special group rates, call or email.

984.227.8560

support@eradimaging.com

Newsletter

Enter your email address to receive our new course alerts.